Skip to main content

Table 3 Efficacy outcomes.

From: Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

 

HES 130/0.4

(n = 88)

NaCl 0.9%

(n = 86)

p

Mean volume of study drug used, ml (SD)

1,379 (886)

1,709 (1,164)

0.0185

Mean time to initial HDS, hours (SD)

11.8 (10.1)

14.3 (11.1)

NS

Number of patients prescribed intravenous catecholamines (%)

88 (88.0)

87 (90.6)

NS

  1. HDS, hemodynamic stabilization; SD, standard deviation; HES, hydroxyethyl starch; NaCI, sodium chloride; NS, not significant.